Nuvectis Pharma, Inc. (NVCT) — SC 13G/A Filings
All SC 13G/A filings from Nuvectis Pharma, Inc.. Browse 4 SC 13G/A reports with AI-powered summaries and risk analysis.
SC 13G/A Filings (4)
- SC 13G/A Filing — Nov 5, 2024
- SC 13G/A Filing — Feb 28, 2024
-
Poradosu Holds 8.7% Stake in Nuvectis Pharma
— Feb 1, 2024
Enrique Poradosu, a key individual associated with Nuvectis Pharma, Inc., filed an amended SC 13G/A on February 1, 2024, indicating he beneficially owns 1,503,8 -
Thomas Peters Discloses 5.2% Stake in Nuvectis Pharma
— Jan 31, 2024
Thomas Peters, an individual investor, has updated his ownership stake in Nuvectis Pharma, Inc. (NUVB) as of December 31, 2023. He now beneficially owns 908,475
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX